1 Product identity
Ingredient risk
Contains restricted ingredients
Niacin 250 mg Sustained Release
BrandBronson Laboratories→Vitamin Tablet or Pill 9 ingredients 1 banned 1 caution DSLD #8272Net contents: 250 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2012-04-26
2 Ingredients (9)
IngredientGroupSafety
Hydroxypropyl MethylcelluloseHypromellose—
Stearic AcidStearic Acid—
TriacetinTriacetin—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
Titanium Dioxide 🇫🇷 🇪🇺 — France banned TiO₂ in food from January 2020, first EU country.
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Niacin — Conditionally Safe
⚠ Flushing at >50 mg
⚠ Hepatotoxicity at high doses
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
Titanium Dioxide — Banned in ≥1 country
⚠ EFSA: can no longer be considered safe as food additive (2021)
⚠ Genotoxicity concern (nanoparticles)
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID8272
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2012-04-26
6 More from Bronson Laboratories
View Bronson Laboratories Safety Scorecard → 213 products
5-HTP 100 mgAcetyl L-Carnitine with CoQ-10Adult Bronson Bears Vitamin C 120 mgAdult Natural Soluble FiberAfrican MangoAll Insurance Vitamin Powder7 Cite this page
Vancouver
Pkhakadze G. Niacin 250 mg Sustained Release — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 30]. Available from: https://supplement.ge/products/niacin-250-mg-sustained-release-8272/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG